Source Production & Equipment Co., Inc. v. Schehr

District Court, E.D. Louisiana·Decided November 1, 2019·No. 2:16-cv-17528·Unknown

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA

SOURCE PRODUCTION & CIVIL ACTION EQUIPMENT CO., INC., ASPECT

TECHNOLOGY LIMITED, SPECMED, LLC, SPEC MED NO. 16-17528

INTELLECTUAL PROPERTY, LLC SECTION M (1) AND SPEC INTELLECTUAL PROPERTY, LLC

VERSUS

KEVEN J. SCHEHR, ISOFLEX USA, ISOFLEX RADIOACTIVE LLC, RICHARD H. MCKANNAY, JR., AND JOHN DOES 1-10

ORDER & REASONS Before the Court are two motions by defendant Kevin Schehr for partial summary judgment on the fraud, breach of legal duties, and Louisiana Unfair Trade Practices Act (“LUTPA”) claims brought against him by plaintiffs Aspect Technology Limited (“ATL”), Specmed, LLC (“Specmed”), Spec Med Intellectual Property, LLC (“SMIP”), and Spec Intellectual Property, LLC (“SPI”) (collectively “Plaintiffs”).1 Plaintiffs respond in opposition,2 and Schehr replies in further support of the motions.3 On October 10, 2019, the Court heard oral argument on the motions.4 Having considered the parties’ memoranda, the statements made at oral argument, the record, and the applicable law, the Court finds that Schehr is entitled to summary judgment dismissing Plaintiffs’ fraud, breach of legal duties, and LUTPA claims related to the shipment and labeling of the Strontium-89 (“Sr-89”), Schehr’s 2015 bonus, and Schehr’s cashing in of his paid time off (“PTO”).

1 R. Docs. 152 & 160. 2 R. Doc. 190. 3 R. Docs. 231 & 233. 4 R. Doc. 313. I. BACKGROUND5 & PENDING MOTIONS This matter concerns the alleged theft of trade secrets, breaches of fiduciary duty and

contract, fraud, and other wrongs allegedly committed by a business’s former employee. SPEC is a supplier of industrial medical radiography equipment and radioactive isotope materials.6 SPEC is an S-corporation that is wholly owned by Richard Dicharry and his wife.7 Schehr is a former executive of SPEC, who was hired in 1995 and worked in various positions during his tenure with the company.8 From 2008, until his termination on July 10, 2016, Schehr was SPEC’s vice president and an officer of the other plaintiff companies.9 The facts pertinent to the pending motions involve three discrete events: (1) a shipment of liquid Sr-89; (2) Schehr’s 2015 bonus; and (3) Schehr’s cash-in of PTO.10 A. The Sr-89 Shipment On November 20, 2014, Richard McKannay, the managing director of Isoflex USA (“IUSA”), wrote to Schehr to propose a business opportunity for SPEC and/or Specmed regarding Sr-89.11 McKannay explained that IUSA was interested in importing Sr-89 to the United States from Russia using SPEC’s Louisiana radioactive materials (“RAM”) license and listing SPEC as the end-user on the Russian forms, relabeling the Sr-89 as a product of the U.S.A., and re-exporting it to China.12 IUSA would act as SPEC’s forwarding agent and handle

5 A more complete factual background is included in this Court’s August 29, 2017, Order & Reasons addressing defendants’ motion to dismiss certain claims raised in Plaintiffs’ first amended complaint (R. Doc. 53), and this Court’s September 30, 3019 Order & Reasons addressing defendants’ motion for summary judgment on Plaintiffs’ trade secrets claims (R. Doc. 312). 6 R. Doc. 53 at 1-2. 7 R. Doc. 160-1 at 2 & 9. 8 R. Doc. 53 at 2. 9 R. Doc. 152-1 at 2. 10 In their opposition memorandum Plaintiffs discuss Schehr’s use of SPEC’s line of credit to fund operating expenses as another act of deception and concealment by Schehr. R. Doc. 190 at 9-10. However, Schehr’s supposed improper use of SPEC’s line of credit is not identified in the operative complaint as a specific act forming the basis for Plaintiffs’ fraud or breach of fiduciary duty claim, so can hardly be said to have been pleaded with the requisite degree of particularity or notice. See R. Doc. 33 at 52-5 & 57-59. Thus, the Court will not discuss the line of credit as the basis of a separate claim. 11 R. Doc. 152-6 at 28-30. 12 Id. the sourcing, sales coordination, and collection, and would pay up-front any fees related to amending SPEC’s RAM license.13 McKannay stated that he thought this would provide a

“straight forward revenue stream [to SPEC] allowing it to leverage on its RAM licensing absent any offsetting expenses.”14 He proposed that IUSA would pay SPEC a minimum of $5,000 per month, and possibly more, based on a proposed formula.15 That same day, Schehr forwarded McKannay’s email to John Munro, who was a vice president of SPEC and Specmed, asking Munro to look at the proposal and “see if it is something we [i.e., SPEC and Specmed] may want to do.”16 On December 18, 2014, Kelley Richardt, SPEC’s regulatory manager, updated SPEC’s RAM license to permit SPEC to distribute approved seal sources, unsealed pellets, and special form Sr-89.17 At Schehr’s request, on March 4, 2015, Richardt sent IUSA the updated version of SPEC’s RAM license.18 On May 16, 2015, McKannay emailed Nathan Gorbach, SPEC’s shipping manager, with instructions for the upcoming test shipment of Sr-89.19 Schehr and Munro were copied on the email.20 On May 26, 2015, Patrick Hardy of IUSA emailed Schehr and Munro informing them that the Sr-89 test shipment departed from Russia and was due to arrive in New Orleans on May 28, 2015.21 On May 28, 2015, Steven Johnson of SPEC issued a product testing report finding that SPEC’s Type-A liquid package container met all requirements for transporting the Sr-89.22 That

13 Id. 14 Id. at 29. 15 Id. at 30. 16 R. Docs. 152-6 at 31 & 36-43. 17 R. Doc. 152-5 at 33-40. 18 R. Doc. 152-6 at 35-43. 19 Id. at 52-54. 20 Id. 21 Id. at 55-56. 22 Id. at 62-66. same day, Richardt asked Schehr whether the Sr-89 was in a liquid form and for information about its sealed source.23 Schehr confirmed to Richardt that the Sr-89 was in liquid form and that the Type-A package was tested for normal conditions.24 Richardt responded that SPEC’s

RAM license allowed for the shipment of Sr-89 in the form of “sealed sources, unsealed pellets and special form.”25 On June 2, 2015, McKannay emailed to Gorbach, copying Schehr and Munro, a product specification certification for the liquid Sr-89 for Richardt to sign.26 Richardt signed the form and Gorbach emailed it back to IUSA on June 5, 2015.27 On June 16, 2015, Richardt requested that SPEC’s RAM license be updated to allow for the possession of Sr-89 in liquid or normal form.28 After Scheher was terminated in July 2016, SPEC made self-disclosures related to the transportation of the liquid Sr-89, one to the United States Census Bureau and the other to the Nuclear Regulatory Commission (“NRC”).29 On March 3, 2017, the Census Bureau wrote to SPEC informing it that the case was closed and that SPEC’s filing of incorrect electronic export information was “due to personnel oversight and a misinterpretation of the definitions of ‘domestic’ and ‘foreign’ described in the Foreign Trade Regulations.”30 On November 16, 2018, the NRC wrote to SPEC and informed SPEC that the NRC viewed the importation of the Sr-89 from Russia to be a significant violation constituting an “escalated enforcement action that may subject [SPEC] to increased inspection effort.”31 The NRC did not impose any civil penalties

23 Id. at 61. 24 Id. at 60. 25 Id. 26 R. Doc. 152-7 at 8-15. 27 Id. at 16-25. 28 Id. at 36. 29 R. Doc. 33 at 41-42. 30 R. Doc. 152-7 at 46. 31 Id. at 47-48. because SPEC had a clean record for two years, but informed SPEC that any future significant violations could result in a civil penalty.32

The foregoing facts are not in dispute.

Free access — add to your briefcase to read the full text and ask questions with AI

Source Production & Equipment Co., Inc. v. Schehr, (E.D. La. 2019).

Source Production & Equipment Co., Inc. v. Schehr (Source Production & Equipment Co., Inc. v. Schehr) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Little v. Liquid Air Corp.
37 F.3d 1069 (Fifth Circuit, 1994)
Lynch Properties, Inc. v. Potomac Insurance
140 F.3d 622 (Fifth Circuit, 1998)
Daniels v. City of Arlington
246 F.3d 500 (Fifth Circuit, 2001)
United States Small Business Administration v. Beaulieu
75 F. App'x 249 (Fifth Circuit, 2003)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Lujan v. National Wildlife Federation
497 U.S. 871 (Supreme Court, 1990)
ODECO Oil & Gas Co. v. Nunez
532 So. 2d 453 (Louisiana Court of Appeal, 1988)
Cheramie Services, Inc. v. Shell Deepwater Production, Inc.
35 So. 3d 1053 (Supreme Court of Louisiana, 2010)
Engineered Mechanical Services, Inc. v. Langlois
464 So. 2d 329 (Louisiana Court of Appeal, 1984)
Boncosky Services, Inc. v. Lampo
751 So. 2d 278 (Louisiana Court of Appeal, 1999)
Defcon, Inc. v. Webb
687 So. 2d 639 (Louisiana Court of Appeal, 1997)
Omega Pain Mgmt. v. Omega Inst. of Health
975 So. 2d 48 (Louisiana Court of Appeal, 2007)
Harrison v. CD Consulting, Inc.
934 So. 2d 166 (Louisiana Court of Appeal, 2006)
Restivo v. Hanger Prosthetics & Orthotics, Inc.
483 F. Supp. 2d 521 (E.D. Louisiana, 2007)
Tolan v. Cotton
134 S. Ct. 1861 (Supreme Court, 2014)